Applied Statistics

Biology: AstraZeneca

Total Score People Score Events Score
25 23 18
Date Event Presentation Speakers
January 24, 2016 10th PMWC 2016 Personalized Medicine World Conference TRACK 1 | Microbiome Therapeutics in The Age of Personalized DNA Sequence David Cook
TRACK 4 | Personalised Healthcare in Metabolic Disease RUTH MARCH
December 2, 2015 PERSONALISED MEDICINES & BIOMARKERS 2015 Panelists Chris Harbron, Darren Hodgson
November 8, 2015 3rd Annual Functional Analysis & Screening Technologies Congress Organoids and Primary Organotypic 3D Culture in Drug Discovery (cont’d) Emma Davies
April 6, 2013 AACR Annual Meetings Drug Development Track: New Drugs on the Horizon 1 Co-Chairpersons: Lori S. Friedman, Genentech, Inc., South San Francisco, CA, and Simon Bailey, Pfizer, Inc., San Diego, CA Dennis Huszar
February 13, 2011 Inositide Signaling in Pharmacology and Disease (X1) PI 3-Kinases (X2) | Using PI3K Pathway Inhibitors to Unravel the Pathway Sabina C. Cosulich
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit 4 Case Study: Conducting Proof-of-Concept Studies in China Karen Atkin
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis New Biomarkers: Opportunities and Challenges Anastasia M. Khoury Christianson
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Comparison of Whole-Cell, Label-Free Assays for GPCR Drug Discovery Matthew Peters
August 5, 2009 Drug Safety Strategies to De-Risk Compounds Developing Computational Biology in Toxicology: Predictions, Data and Culture Sherri Matis-Mitchell
How Can Systems Biology Help in De-risking Molecules? David Cook
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety Monitoring Hepatotoxicity in Clinical Trials Mark H. Steinberg
June 4, 2009 Structure-Based Drug Design Supplementing Structural Information with Biophysical Data: Adding Value and Understanding in Lead Generation Stefan Geschwindner
Designing Drugs against Multiple Parameters: Scoring Functions for Multi-Parameter Ligand Based De Novo Design James R. Damewood
December 7, 2008 Antibody Engineering Technology Workshops : Balancing Power and Simplicity in Real Time, Label-Free Characterization/Selection of Antibodies and Development of Biopharmaceuticals: The Added Value of Biosensors Johan Lindberg
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Session Chair :Track 1-10 James Jianguo Li
Small Molecule Inhibitors Targeting Mutation Driven Cancers :Track 2-4 (I) Jeannie Hou
September 29, 2008 Genomic Biomarkers Personalized Healthcare – Where Are We Now? Ruth E. March
September 29, 2008 Metabolic Biomarkers Metabolomics/Proteomics: Tools for Biomarker Discovery within Safety Assessment Johan Lindberg
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 15: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part III) (13:30-17:00) Xiaolin Zhang
Session 15: AZD1152, an Aurora B Kinase Inhibitor, Demonstrates Potent Antitumour Efficacy in Preclinical Models (16:15-16:40) Xiaolin Zhang
September 27, 2007 Protein Expression Europe (Sep 27-28) Protein Localization (13:25-16:15) Stefan R. Schmidt
Protein Localization: Comments by Session Chairperson (13:25-13:30) Stefan R. Schmidt
Breakfast BuzZ Sessions (08:00-09:00) Niek Dekker
Breakfast BuzZ Session IV: Sampling Expression Space (08:00-09:00) Niek Dekker
Drug Discovery Applications (13:00-15:15) Niek Dekker
Drug Discovery Applications: Purified Membrane Protein Targets for Drug Discovery (13:45-14:15) Niek Dekker
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: PHARMACOGENETICS: Major Pharmacogenetics Studies Using a Combination of Genome-Wide Tagging SNPs and High Density SNP Genotyping in Candidate Genes (10:05-10:35) Neil Gibson
Third annual Genomic Biomarkers: PHARMACOGENETICS (08:30-11:30) Neil Gibson
Eight Annual Metabolic Biomarkers: METABOLIC BIOMARKER DISCOVERY (08:30-11:00) Stephen Furlong
Eight Annual Metabolic Biomarkers; METABOLIC BIOMARKER DISCOVERY: Urine and Plasma Biomarkers in Schizophrenia (09:05-09:35) Stephen Furlong
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.